COMPANY

Alopexx

HQ: Cambridge, MA source · alopexx.com ↗ · New England

Keywords: antibody vaccine monoclonal antibody infectious disease Neisseria Gonorrhoeae

Location: Cambridge, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Nov 29, 2017 Trial start Phase 2: Trial to Assess the Efficacy of F598 in Preventing an Experimental Urethral Infection With N. Gonorrhoeae in Healthy Males source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT03222401	Trial to Assess the Efficacy of F598 in Preventing an Experimental Urethral Infection With N. Gonorrhoeae in Healthy Males	Phase 2	Terminated	Nov 29, 2017	Mar 2, 2018 (actual)